AI Article Synopsis

  • The study investigates oncologists' awareness of ototoxicity and monitoring practices in head and neck cancer patients in South India using semi-structured interviews.
  • All oncologists recognized the ototoxic effects of treatments but considered the resulting hearing loss minor and did not prioritize counseling on this issue.
  • Despite awareness of ototoxicity monitoring programs, none had implemented them, indicating a need for improved education and advocacy among oncologists about the importance of these programs.

Article Abstract

Aim: The perspectives and practices of healthcare professionals regarding ototoxicity in individuals with head and neck cancers are important for the implementation of ototoxicity monitoring. The current study aims to explore the oncologist's awareness and perspectives of ototoxicity and ototoxicity monitoring for individuals with head and neck cancer in a South-Indian district, using qualitative semi-structured interviews.

Method: The COnsolidated criteria for REporting Qualitative research (COREQ) Checklist was used to guide the method of the current qualitative study. A conceptual framework was developed for the formulation of the interview guides. Three medical oncologists and six radiation oncologists from cancer care centres participated in the study. The interviews were audio recorded and transcribed verbatim. Thematic analysis was carried out using a hybrid inductive-deductive approach to present the findings under the respective overarching themes.

Results: All oncologists are aware of the ototoxic effects caused by radiation therapy and chemoradiotherapy. It was consistently reported that the severity of the hearing loss was not substantial enough to warrant significant concern. Ototoxicity is not emphasized during the counseling process. All participants reported having awareness and knowledge of ototoxicity monitoring programs and understood their importance. However, none of them reported the implementation of an ototoxicity monitoring program in their facility.

Discussion: It is imperative to enhance the knowledge and understanding of the ototoxic nature of cancer treatment modalities among oncologists. It is crucial to raise awareness regarding the significance of ototoxicity monitoring programs among all physicians involved in the treatment of patients with cancer for maximum impact. The barriers to implementing ototoxicity monitoring programs in high- and low-income countries are similar. The models implemented in high-income countries can be adapted for use in low-middle income countries with suitable restructuring.

Conclusion: The current study provides valuable insights into the status of ototoxicity monitoring in the South-Indian context. The findings align with the key components of the health belief model, including perceived susceptibility, perceived barriers, and cues to action. Involving oncologists in the planning phase of the ototoxicity monitoring programs can help tailor future research questions and solutions to improve quality of life, foster collaboration among healthcare professionals, and produce actionable outcomes that may influence policy on ototoxicity monitoring.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698418PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0312847PLOS

Publication Analysis

Top Keywords

ototoxicity monitoring
40
monitoring programs
16
ototoxicity
13
head neck
12
monitoring
10
neck cancer
8
qualitative study
8
healthcare professionals
8
individuals head
8
implementation ototoxicity
8

Similar Publications

Article Synopsis
  • The study investigates oncologists' awareness of ototoxicity and monitoring practices in head and neck cancer patients in South India using semi-structured interviews.
  • All oncologists recognized the ototoxic effects of treatments but considered the resulting hearing loss minor and did not prioritize counseling on this issue.
  • Despite awareness of ototoxicity monitoring programs, none had implemented them, indicating a need for improved education and advocacy among oncologists about the importance of these programs.
View Article and Find Full Text PDF

Aim: To study the adverse reactions that develop as a result of complex antibiotic therapy in patients with non-tuberculous lung mycobacterial (NTML) and to determine methods for their elimination without compromising the effectiveness of NTML treatment.

Materials And Methods: Examined 147 patients with confirmed NTML, for which they received treatment in accordance with the results of drug susceptibility of the pathogen. Before and during treatment, a study of clinical, biochemical blood tests, urinalysis, electrocardiogram, external respiration function, ultrasound of the abdominal organs and kidneys was performed.

View Article and Find Full Text PDF

Objectives: Valid wireless automated Békésy-like audiometry (ABA) outside a sound booth that includes extended high frequencies (EHF) would increase access to monitoring programs for individuals at risk for hearing loss, particularly those at risk for ototoxicity. The purpose of the study was to compare thresholds obtained with (1) manual audiometry using an Interacoustics Equinox and modified Hughson-Westlake 5 dB threshold technique to automated audiometry using the Wireless Automated Hearing Test System (WAHTS) and a Békésy-like 2 dB threshold technique inside a sound booth, and (2) ABA measured in the sound booth to ABA measured outside the sound booth.

Design: Cross-sectional study including 28 typically developing children and adolescents (mean = 14.

View Article and Find Full Text PDF

Background: In 2021, there were approximately 450,000 cases of drug-resistant tuberculosis (DR-TB) worldwide. The treatment of DR-TB historically included expensive and toxic injectable drugs leading to adverse effects including ototoxicity and Electrocardiogram (ECG) abnormalities. This study described the perspectives of healthcare providers and people with DR-TB on the usability of simplified audiometry and ECG for monitoring treatment adverse effects.

View Article and Find Full Text PDF

Healthcare professionals' knowledge and practices in managing ototoxicity in children with cancer.

S Afr J Commun Disord

November 2024

Department of Audiology, Faculty of Health Sciences, University of KwaZulu-Natal, Durban.

Background:  Platinum-based chemotherapy poses a risk of ototoxic hearing loss, the effects of which can be devastating in paediatrics with cancer. Childhood hearing loss significantly impacts speech and language acquisition, and educational, psychosocial and emotional development, consequently negatively impacting quality of life. Adequate knowledge and effective management by healthcare professionals in the team managing paediatrics with cancer are, therefore, pivotal to mitigating the severity and impact on quality of life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!